Amneal Pharmaceuticals Inc (AMRX) Reports Mixed 2023 Financial Results
Despite Revenue Growth, Company Faces GAAP Net Loss and Provides 2024 Guidance
Source: yahoo.com
Stay updated with breaking news from Fy 2023. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Despite Revenue Growth, Company Faces GAAP Net Loss and Provides 2024 Guidance
US & Canada News News: H-1B denial rates remained low in FY 2023 compared to the Trump-years. Increased denials for medium-sized filers accounted for the rise in denial rate
Strategic Focus and Pipeline Advancements Amid Financial Prudence
Net Sales Dip as Company Strengthens Portfolio, Adjusted EBITDA Rises
Initiates Quarterly Dividend Following a Year of Strategic Execution